Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 7, Issue 8, Pages 208
Publisher
MDPI AG
Online
2018-08-10
DOI
10.3390/jcm7080208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis
- (2018) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
- (2017) Latania K. Logan et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance
- (2017) Yee-Huang Ku et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques
- (2017) Micheline A. H. Soudeiha et al. Frontiers in Cellular and Infection Microbiology
- Efficacy and Safety of High Loading Dose of Colistin in Multidrug-Resistant Acinetobacter baumannii: A Prospective Cohort Study
- (2017) Wasan Katip et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Efficacy and Toxicity of High-Dose Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections: A Comparative Study of a Matched Series
- (2016) Ahlem Trifi et al. CHEMOTHERAPY
- Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
- (2016) Oren Zusman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis
- (2016) Elda Righi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia
- (2015) Antonis Valachis et al. CRITICAL CARE MEDICINE
- Optimum treatment strategies for carbapenem-resistantAcinetobacter baumanniibacteremia
- (2015) José Garnacho-Montero et al. Expert Review of Anti-Infective Therapy
- Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
- (2015) Zhijin Chen et al. Scientific Reports
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
- (2014) J. Alexander Viehman et al. DRUGS
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation